Host: |
Rabbit |
Applications: |
WB/IF |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-IGFBP5 (21-272) is suitable for use in Western Blot and Immunofluorescence research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IF/ICC 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
IGFBP5 |
Gene ID: |
3488 |
Uniprot ID: |
IBP5_HUMAN |
Immunogen Region: |
21-272 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 21-272 of human IGFBP5 (NP_000590.1). |
Immunogen Sequence: |
LGSFVHCEPCDEKALSMCPP SPLGCELVKEPGCGCCMTCA LAEGQSCGVYTERCAQGLRC LPRQDEEKPLHALLHGRGVC LNEKSYREQVKIERDSREHE EPTTSEMAEETYSPKIFRPK HTRISELKAEAVKKDRRKKL TQSKFVGGAENTAHPRIISA PEMRQESEQGPCRRHMEASL QELKASPRMVPRAVYLPNCD RKGFYKRKQCKPSRGRKRGI CWCVDKYGMKLPGMEYVDG |
Tissue Specificity | Osteosarcoma, and at lower levels in liver, kidney and brain. |
Function | IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. |
Protein Name | Insulin-Like Growth Factor-Binding Protein 5Ibp-5Igf-Binding Protein 5Igfbp-5 |
Database Links | Reactome: R-HSA-381426Reactome: R-HSA-8957275 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Insulin-Like Growth Factor-Binding Protein 5 antibodyAnti-Ibp-5 antibodyAnti-Igf-Binding Protein 5 antibodyAnti-Igfbp-5 antibodyAnti-IGFBP5 antibodyAnti-IBP5 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance